Why is a LAL endotoxin test specifically required for injectable Drostanolone Propionate?

The LAL (Limulus Amebocyte Lysate) test detects bacterial endotoxins — heat-stable lipopolysaccharide fragments that cause fever and inflammatory responses when injected. Standard sterilisation eliminates viable bacteria but does not destroy endotoxins, so LAL testing is the only reliable method to confirm parenteral-grade safety. For a multi-dose vial accessed repeatedly over a cycle, endotoxin control is especially critical.

How does a Certificate of Analysis link to a specific vial of Drostanolone 150?

Each Certificate of Analysis is generated against a unique production lot number. The lot number printed on the vial label corresponds directly to the analytical records — HPLC potency value and LAL endotoxin result — produced for that specific manufacturing run. This traceability means the quality data accompanying the product is not generic; it belongs to the exact batch the vial was drawn from.

Why does the 150mg/ml concentration make HPLC verification more important than at lower concentrations?

At 150mg/ml, a formulation deviation of 5% represents a larger absolute dose error per injection than the same percentage deviation at 100mg/ml. Tighter concentration demands tighter analytical confirmation. HPLC quantification at this tier ensures the higher active load per millilitre is accurately delivered rather than assumed, which is why Elite Pharm applies the same analytical gate regardless of vial concentration within its injectable range.

Can a 1ml luer-lock syringe handle the injection volumes typical for Drostanolone 150 at 150mg/ml?

Yes. At 150mg/ml, a 100mg dose draws to 0.67ml and a 150mg dose draws to exactly 1.0ml — both within the capacity of a standard 1ml luer-lock syringe. This keeps injection volumes compact across the most common per-session doses. After drawing, the vial stopper should be swabbed with alcohol before each access, and the vial stored upright at room temperature away from light between uses. (2) angle_used

hochdosis_formel

Elite Pharm

Drostanolone 150 150mg/ml 10ml Vial by Elite Pharm

Name: Drostanolone 150
Brand: Elite Pharm
SKU: INJ-DROP-ELI-150-027
Price: 50.00 EUR
Availability: InStock

Elite Pharm Drostanolone 150 is a pharmaceutical-grade injectable androgenic compound delivering Drostanolone Propionate at 150mg per millilitre in a 10ml multi-dose vial, with batch-level laboratory verification as its defining quality commitment. Each production lot undergoes reversed-phase HPLC potency analysis to confirm the declared concentration, paired with a Limulus Amebocyte Lysate assay validating parenteral-grade endotoxin limits. Both test results are documented against the specific lot number: traceable, retention-archived, and available as a Certificate of Analysis.

€50.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Batch-specific HPLC potency confirmation ensures declared 150mg/ml is analytically verified, not assumed
LAL endotoxin assay clears each lot to parenteral-grade safety standards before distribution
Highest concentration in the Drostanolone Propionate group reduces injection volume per dose
Lot-numbered Certificate of Analysis provides a direct traceability link between vial and laboratory data
Two independent analytical release gates operate in sequence — neither substitutes for the other
10ml multi-dose vial format supports extended cycle protocols within a single analytically documented unit

Phase	Weekly Dose	Notes
Quality verification period (Weeks 1–2)	300mg/week (EOD, 1.0ml per injection)	Baseline bloods drawn before first injection; CoA lot number recorded
Active phase (Weeks 3–8)	300–450mg/week (EOD)	Mid-cycle lipid and haematocrit panel; compare to pre-cycle baseline
Pre-exit taper (Week 9–10)	150–300mg/week	Final injection timed 4–5 days before cycle conclusion to allow clearance

Key takeaways

Verify the batch CoA before injecting — lot-specific HPLC data confirms 150mg/ml accuracy.
Demand LAL results: endotoxin clearance is mandatory for any injectable product.
Choose 150mg/ml to reduce oil volume per dose without sacrificing androgenic load.
Cross-reference the vial lot number against the Certificate of Analysis on delivery.
Store the multi-dose vial properly: upright, room temperature, stopper swabbed before each draw.

What Laboratory Verification Means for Elite Pharm Drostanolone 150

Elite Pharm Drostanolone 150 is defined by the intersection of high-concentration androgenic formulation and documented analytical quality control — two pillars that operate independently yet are released together on a single Certificate of Analysis per production batch. Drostanolone Propionate at 150mg/ml constitutes the active payload; the LAL and HPLC records constitute the evidence that the payload is exactly what the label states.

Reversed-phase HPLC (high-performance liquid chromatography) quantifies the Drostanolone Propionate content of each batch against a certified reference standard. The instrument separates the active compound from its carrier oil, any degradation products, and process residuals — then calculates the concentration from peak-area ratios. This method generates a numerical result, not a pass/fail impression, and Elite Pharm retains that result at batch level so each 10ml vial is traceable to a specific analytical record.

LAL Endotoxin Testing: The Parenteral Safety Gate

The Limulus Amebocyte Lysate test detects bacterial endotoxins — lipopolysaccharide fragments that survive sterilisation and cause pyrogenic responses upon injection. Elite Pharm runs LAL testing on each batch before release; the assay uses the clotting reaction of horseshoe-crab amebocyte lysate to detect endotoxin concentrations below the threshold established for parenteral products. Compared to sterility testing alone, LAL assay detects endotoxin at sub-microgram levels where sterility culture methods would return a false-clear result — a distinction that matters specifically for multi-dose injectable vials accessed repeatedly over weeks.

Concentration and Quality Control as Integrated Decisions

At 150mg/ml, Elite Pharm Drostanolone 150 carries the highest concentration available within this Drostanolone Propionate product group. Higher concentration per millilitre means lower total injection volume per dose — a practical benefit — but it also demands tighter manufacturing precision: a formulation error of even 5% at 150mg/ml produces a larger absolute deviation per dose than the same error at 100mg/ml. HPLC quantification at this concentration tier is therefore not a routine formality but a technical requirement. Elite Pharm's dual analytical release gate addresses this directly: HPLC confirms the concentration is accurate; LAL confirms the solution is safe to inject.

Usage

Retrieve the Certificate of Analysis for your vial's lot number and confirm the HPLC result shows Drostanolone Propionate concentration within the validated range before first use.
Visually inspect the vial: solution should be clear, colourless to pale yellow, and free of particulate matter — discard if cloudy.
Swab the rubber stopper with a 70% isopropyl alcohol wipe and allow it to dry fully before inserting the needle.
Draw the calculated volume into a 1ml luer-lock syringe; at 150mg/ml a 150mg dose corresponds to exactly 1.0ml.
Administer via intramuscular injection into a large muscle group (glute, vastus lateralis) using standard aseptic technique; rotate sites across every-other-day injections.
Store the vial upright at room temperature (15–25°C), protected from direct light; log each draw date and remaining volume against the lot-specific CoA to maintain a traceable usage record.

Warnings

Contraindications: Not indicated for women, minors, or individuals with androgen-sensitive malignancies, existing hepatic dysfunction, or elevated haematocrit. Consult a licensed physician before initiating any injectable androgenic compound.

Side Effects: Androgenic effects including accelerated scalp hair loss in genetically predisposed individuals, acne, and changes in sebum production. HDL suppression has been documented in clinical androgenic studies; lipid panels should be interpreted against individual cardiovascular risk.

Monitoring: Obtain a complete blood count, lipid panel, and liver enzyme screen before cycle initiation. Repeat at the mid-cycle point. Track haematocrit; elevated values increase cardiovascular risk and may require dose adjustment or cycle interruption.

PCT: Drostanolone Propionate's propionate ester clears systemically within approximately one week of the final injection. Post-cycle therapy with a SERM (e.g. Nolvadex or Clomid) should begin promptly after clearance to support endogenous testosterone axis recovery.

Frequently asked questions

What does HPLC testing confirm in Elite Pharm Drostanolone 150?: HPLC (high-performance liquid chromatography) confirms that the Drostanolone Propionate concentration in each production batch matches the label-declared 150mg/ml within validated tolerance limits. The instrument separates the active compound from the carrier oil and any impurities, calculates concentration from peak-area ratios against a certified reference standard, and generates a numerical result retained in the batch Certificate of Analysis.
Why is a LAL endotoxin test specifically required for injectable Drostanolone Propionate?: The LAL (Limulus Amebocyte Lysate) test detects bacterial endotoxins — heat-stable lipopolysaccharide fragments that cause fever and inflammatory responses when injected. Standard sterilisation eliminates viable bacteria but does not destroy endotoxins, so LAL testing is the only reliable method to confirm parenteral-grade safety. For a multi-dose vial accessed repeatedly over a cycle, endotoxin control is especially critical.
How does a Certificate of Analysis link to a specific vial of Drostanolone 150?: Each Certificate of Analysis is generated against a unique production lot number. The lot number printed on the vial label corresponds directly to the analytical records — HPLC potency value and LAL endotoxin result — produced for that specific manufacturing run. This traceability means the quality data accompanying the product is not generic; it belongs to the exact batch the vial was drawn from.
Why does the 150mg/ml concentration make HPLC verification more important than at lower concentrations?: At 150mg/ml, a formulation deviation of 5% represents a larger absolute dose error per injection than the same percentage deviation at 100mg/ml. Tighter concentration demands tighter analytical confirmation. HPLC quantification at this tier ensures the higher active load per millilitre is accurately delivered rather than assumed, which is why Elite Pharm applies the same analytical gate regardless of vial concentration within its injectable range.
Can a 1ml luer-lock syringe handle the injection volumes typical for Drostanolone 150 at 150mg/ml?: Yes. At 150mg/ml, a 100mg dose draws to 0.67ml and a 150mg dose draws to exactly 1.0ml — both within the capacity of a standard 1ml luer-lock syringe. This keeps injection volumes compact across the most common per-session doses. After drawing, the vial stopper should be swabbed with alcohol before each access, and the vial stored upright at room temperature away from light between uses. (2) angle_used

Manufacturer

Elite Pharm was established as a European pharmaceutical-grade injectable manufacturer with a defined focus: a narrow, injectable-only product range where consistent documentation standards could be maintained across every SKU rather than spread across a broad multi-format catalogue. The brand's operating philosophy centres on batch-level accountability — the position that a product's quality claim is only meaningful when it is backed by lot-specific analytical data rather than a standing process certificate. For Drostanolone 150, this translates into two laboratory methods applied sequentially to each production run: reversed-phase HPLC confirms active concentration, and LAL endotoxin testing confirms injectable-grade safety. Both results are retained under the specific lot number accompanying each vial, making Elite Pharm's quality record for this product directly traceable rather than generic.

Product details

Brand	Elite Pharm
Active ingredient	drostanolone propionate
Also known as	Masteron, Drolban, Propha-Masteron, Drostanolone 150, Elite Pharm Masteron
Strength	150 mg
Form	Vial
Pack size	1 piece
Item number	INJ-DROP-ELI-150-027

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Optimal Dosage

Propha-Masteron 100mg/ml 10ml Vial by Beligas Pharmaceuticals

Propha-Masteron is an oil-based injectable solution delivering Drostanolone Propionate at 100mg/ml, distinguished by its capacity to bypass hepatic first-pass metabolism entirely — a pharmacokinetic advantage that oral androgen compounds cannot replicate. Each 10ml multi-dose vial provides a full cycle's supply of pharmaceutical-grade active, with systemic absorption occurring directly through intramuscular tissue into the bloodstream. Quality assurance is built into every lot: HPLC potency verification, LAL endotoxin screening, and GMP-certified filling suites are standard — not optional — at Beligas Pharmaceuticals.

€46.00

Masten-100 100mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Fast Acting

Masten-100 100mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Masten-100 is a fast-acting injectable androgenic compound delivering Drostanolone Propionate at 100mg/ml in single-dose 1ml ampoules, specifically engineered for rapid tissue uptake and measurable efficacy within the first days of administration. The propionate ester's short carbon chain enables peak plasma concentrations to establish quickly — typically within 24–48 hours of the first injection — making it one of the fastest-onset drostanolone formulations available. Every lot is released only after HPLC potency confirmation and LAL endotoxin screening; sterility is assured via Ph. Eur. 2.6.1-compliant testing conducted at BM Pharmaceuticals' GMP-certified facility.

€47.00

High Concentration

MasterTrex 150mg/ml 10ml Vial by Concentrex Labs

MasterTrex is a high-concentration Drostanolone Propionate injectable, formulated at 150 mg/ml in a 10 ml multi-dose vial and engineered for athletes who demand precise, schedule-driven injection timing across their cutting or pre-contest phase. At 150 mg/ml, each draw delivers a clinically meaningful dose in a compact volume, making every-other-day or every-third-day scheduling straightforward without excess injection site load. Quality is locked in at batch level: HPLC-quantified potency verification and LAL endotoxin testing are completed before any MasterTrex vial leaves the Concentrex Labs facility.

€50.00

Brand Quality

Masteron 100 100mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma Masteron 100 is a drostanolone propionate injectable solution at 100mg/ml in a 10ml multi-dose vial, specifically suited to frontloading protocols that compress the time-to-steady-state window at the opening of a cycle. Because the propionate ester releases active drostanolone within a short half-life of approximately 2–3 days, calculated loading doses can bring circulating androgen levels to the target therapeutic range within the first 72 hours rather than waiting the usual week or more. Dragon-Pharma batch-releases every vial only after HPLC potency verification and LAL endotoxin clearance — two independent quality gates applied sequentially before product leaves the facility.

€42.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00